Status:
UNKNOWN
Hydroxychloroquine in COVID-19 Patients
Lead Sponsor:
Samah Lutfy
Conditions:
COVID-19
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Many reports argued about the possible beneficial effects of Hydroxychloroquine in treating COVID-19 patients and this study was designed to investigate this claim
Eligibility Criteria
Inclusion
- Confirmed cases of SARS-CoV-2 by PCR
Exclusion
- less than 18 years old known hypersensitivity to the drug
Key Trial Info
Start Date :
March 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04394442
Start Date
March 21 2020
End Date
August 1 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SNH
Mecca, Saudi Arabia